How Bacteria Eat Penicillin

Scientists work out the specific genes and biochemical steps required for digesting the very drugs designed to kill microbes.

By Shawna Williams | April 30, 2018

Erlenmeyer flask with crystals at the bottomResearchers synthesized some penicillin breakdown products themselves for use in the experiments.TERENCE CROFTSome bacteria take antibiotic resistance a step further: they chow down on the very compounds designed to kill microbes and use them as fuel. Researchers detail today (April 30) in Nature Chemical Biology how some bacteria accomplish this feat, including the genes and enzymes involved in digesting penicillin. They hope the knowledge will eventually be put to work in applications such as breaking down antibiotics in, for example, hospital waste or farm runoff, and constructing novel drug compounds.

“Basically, if you look for it it’s there in when it comes to bacterial degradation of compounds. . . . Somebody out there will degrade just about everything,” says Jo Handelsman, a microbiologist at the University of Wisconsin-Madison. “I don’t think that penicillin-producing strains of Penicillium are absolutely ubiquitous in soil, so it is kind of interesting that it is easy to find these degraders, even though they may not individually have encountered penicillin before.”

Guatam Dantas, a microbiologist at Washington University in St. Louis, stumbled across the phenomenon of antibiotic-eating bacteria during an earlier study looking for bacteria that can break down toxins, he explains. In that study, his group chose some antibiotics as controls to measure microbes’ responses to compounds they couldn’t eat—or so the researchers thought.

Instead, Dantas was surprised to find that some of the bacteria could, in fact, eat the drugs, and he began asking colleagues to send him soil samples from different places so his team could test for the presence of such microbes. As it turned out, they were everywhere. He also found examples of the phenomenon in the scientific literature going back to the 1960s.

“What has been missing has been any kind of mechanistic elucidation of how this occurs,” he says. So his team set out to deconstruct the steps needed to break down penicillin—selected because it and its derivatives are the largest class of antibiotics—into microbial fuel.

The project ended up taking about a decade, Dantas tells The Scientist, largely because the penicillin-eating microbes aren’t model organisms, and the team had to develop or adapt techniques to knock out certain genes and otherwise manipulate them.

As part of their experiments, the researchers exposed the microbes to one type of partially broken-down penicillin compound at a time to determine the order of steps in the degradation pathway. To do so, they first had to synthesize some of the compounds themselves. Once the researchers thought they’d figured out all the genes involved in the pathway, they transfected them into E. coli and gave them the ability to eat penicillin.

Dantas suggests that, similarly, the genes could be used to specially engineer microbes to break down antibiotic pollutants—for example, in waste from farms where the drugs have been used in livestock or in effluent from hospitals.

The idea of engineering antibiotic-eating bacteria to combat the spread of drug resistance is counterintuitive, but Dantas is cognizant of safety concerns. The gene used in the first step of the pathway, which codes for an enzyme that deactivates penicillin, is the same one already used by penicillin-resistant pathogens, so, he argues, such an approach wouldn’t be introducing new resistance genes to the environment—though he concedes that “you never want to play around with any kind of genetic engineering without very carefully thinking of the risk and what the mitigation strategies might be.” A lower-risk alternative, he says, might be to deploy the bacterial enzymes but not bacteria themselves.

glowing blue plateAn experiment to detect cleavage of a penicillin product by bacterial enzymesTERENCE CROFTThe idea is “very ambitious,” but such a system would likely be too expensive to make significant headway on cleaning up antibiotics in the environment, says Julian Davies, a microbiologist at the University of British Columbia in Vancouver who was not involved in the study.

Microbiologist Xiaohui Zhou of the University of Connecticut sees promise in putting the enzymes to work making new antibiotics, because they cut existing compounds in predictable places, and the resulting pieces could be mixed and matched to create semi-synthetic drugs.

Now that the methodologies to identify these enzymes and their pathways have been worked out, Dantas says he expects other researchers will be able to begin discovering enzymes and pathways microbes use to break down other types of antibiotics, further adding to the biotechnological tools chemists and biochemists have at their disposal.

T.S. Crofts, “Shared strategies for β-lactam catabolism in the soil microbiome,” Nat Chem Biol, doi:10.1038/s41589-018-0052, 2018.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: James V. Kohl

James V. Kohl

Posts: 532

May 1, 2018

....some of the bacteria could, in fact, eat the drugs... As it turned out, they were everywhere. He also found examples of the phenomenon in the scientific literature going back to the 1960s.

In 1964, McEwen et al, linked the creation of the sun's anti-entropic virucidal energy from Schrödinger's claims in What is Life? (1944) to the creation of ATP and the creation of RNA. Now, others like McEwen know that RNA interference biophysically constrains viral latency.

In 1968, Frohlich speculated that the highly ordered storage of quantized energy in species from microbes to humans linked hydrogen-atom transfer to the functional structure of cell membranes via the hydrogen bonds of molecules, or other dipolar constituents, which he linked to the shared energy supply that biophysically constrains life.

Fifty years later only theorists and other pseudoscientists have failed to recognize the facts that link experimental evidence of differences in the energy of photons to the proton motive force, which links the potential of hydrogen (pH) to biophysically constrained viral latency and all biodiversity on Earth.

Serious scientists will meet during Schrödinger at 75 - The Future of Biology - September 2018 to discuss the overwhelming amount of human idiocy exemplified in the works of theorists who failed to learn that life is "All about that base." Without the quantized energy-dependent creation of the base pairs, viral latency could not be biophysically constrained and entropy would be used to explain the evolution of biodiversity manifested in sympatric speciation.

Popular Now

  1. Two University of Rochester Professors Resign in Protest
  2. Dartmouth Professor Investigated for Sexual Misconduct Retires
  3. Theranos Leaders Indicted For Fraud
    The Nutshell Theranos Leaders Indicted For Fraud

    Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

  4. Koko the Signing Gorilla Dies at 46